“…Additionally, the models explore genetic pathways and mechanisms underlying disease development such as expansions, aberrant splicing, repeat-associated non-AUG (RAN) translation and RNA frameshifting. By using methods such as lentiviral transduction, microinjection with mRNA and transposase-mediated recombination, transgenic models were generated in yeast [87,88], human embryonic kidney (HEK) 293T cells [89][90][91], C. elegans [92][93][94][95], D. melanogaster [96][97][98], zebrafish [99][100][101][102], the mouse [27,[103][104][105][106][107][108][109][110][111][112][113], rat [83,114], sheep [115], pig [116,117] and monkey [118][119][120][121]. Additionally, patient-derived cells were reprogrammed into iPSCs and used to model polyQ diseases [122][123][124][125][126][127][128].…”